We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Finger Stick Blood Test Detects Early Signs of Heart Attack Before it Occurs

By LabMedica International staff writers
Posted on 21 Jun 2022
Image: Micro-device designed to sense blood clots could pick up early signs of heart attack (Photo courtesy of Pexels)
Image: Micro-device designed to sense blood clots could pick up early signs of heart attack (Photo courtesy of Pexels)

Heart attacks and strokes are the world’s leading cause of death. Many are caused by blood clots that block the flow of blood to the heart, often in at-risk individuals without any physical warning. However, long before a heart attack or stroke occurs, tiny changes in the blood begin taking place. Often, blood flow is disturbed, leading to blood clotting and inflammation which can block blood vessels. Now, researchers are developing a biomedical micro-device to detect these subtle platelet changes before a heart attack or stroke takes place.

Using a pin-prick test, the micro-device developed by scientists at the University of Sydney (Sydney, Australia) would take a blood sample from a person’s finger. The sample would then be analyzed for platelet clotting and white cell inflammation responses, information that would be immediately processed by an external operating system. The scientists will undertake further engineering development for the microdevice, which is predicated on an integrated microfluidic chip. The team is also working to build highly sensitive computational fluid dynamics simulations to better understand the impact of mechanical forces that could lead to blood pooling and clots.

“How this device would work is that an at-risk person, for example, someone with heart disease, would use it daily. Using a finger prick test, the device would monitor their blood and alert them to any potentially dangerous changes. If a change was detected, they would need to present for more monitoring at a hospital," said Dr. Arnold Lining Ju, an award-winning biomedical engineer from the University of Sydney's Nano Institute and School of Biomedical Engineering.

Research assistant Laura Moldovan said that, historically, it has been difficult to predict when a heart attack or stroke might happen: “They appear to occur at random, sometimes without any physical symptoms, however in fact there are tiny physical changes that occur in the blood – the key to this device is being able to sensitively monitor these microscopic changes.”

Related Links:
University of Sydney 

New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Gold Member
Hematology Analyzer
Medonic M32B

Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: Private equity firms Blackstone and TPG have joined forces to acquire Hologic in a major healthcare deal (Photo courtesy of Hologic)

Hologic to be Acquired by Blackstone and TPG

Hologic (Marlborough, MA, USA) has entered into a definitive agreement to be acquired by funds managed by Blackstone (New York, NY, USA) and TPG (San Francisco, CA, USA) in a transaction valued at up to... Read more